45 related articles for article (PubMed ID: 34677543)
1. Use of ultrafiltration/diafiltration for the processing of antisense oligonucleotides.
Gronke RS; Ruanjaikaen K; Delavari A; Immel-Brown JP; Penrod JC; Lam Y; Antia FD
Biotechnol Prog; 2023; 39(4):e3350. PubMed ID: 37186510
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticulate Impurities in Pharmaceutical-Grade Sugars and their Interference with Light Scattering-Based Analysis of Protein Formulations.
Weinbuch D; Cheung JK; Ketelaars J; Filipe V; Hawe A; den Engelsman J; Jiskoot W
Pharm Res; 2015 Jul; 32(7):2419-27. PubMed ID: 25630820
[TBL] [Abstract][Full Text] [Related]
3. Multi-criteria manufacturability indices for ranking high-concentration monoclonal antibody formulations.
Yang Y; Velayudhan A; Thornhill NF; Farid SS
Biotechnol Bioeng; 2017 Sep; 114(9):2043-2056. PubMed ID: 28464235
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of ultra- and diafiltration processes by Kalman-filtered Raman measurements.
Rolinger L; Hubbuch J; Rüdt M
Anal Bioanal Chem; 2023 Feb; 415(5):841-854. PubMed ID: 36651972
[TBL] [Abstract][Full Text] [Related]
5. Influence of Nano-Particulate Impurities and β-glucans on the Stability of Protein-Based Formulations.
Satapathy SR; Sahoo RN; Nayak AK
Curr Drug Deliv; 2024 Jan; ():. PubMed ID: 38299274
[TBL] [Abstract][Full Text] [Related]
6. The role of intermolecular interactions on monoclonal antibody filtration through virus removal membranes.
Billups M; Minervini M; Holstein M; Feroz H; Ranjan S; Hung J; Zydney AL
Biotechnol J; 2023 Dec; 18(12):e2300265. PubMed ID: 37641433
[TBL] [Abstract][Full Text] [Related]
7. Buffer effects on protein sieving losses in ultrafiltration and their relationship to biophysical properties.
Mohammadzadehmarandi A; Zydney AL
Biotechnol Prog; 2024 May; ():e3481. PubMed ID: 38780204
[TBL] [Abstract][Full Text] [Related]
8. Impact of ethanol on continuous inline diafiltration of liposomal drug products.
Worsham RD; Thomas V; Farid SS
Biotechnol J; 2023 Nov; 18(11):e2300194. PubMed ID: 37531572
[TBL] [Abstract][Full Text] [Related]
9. Single Pass Diafiltration Integrated into a Fully Continuous mAb Purification Process.
Rucker-Pezzini J; Arnold L; Hill-Byrne K; Sharp T; Avazhanskiy M; Forespring C
Biotechnol Bioeng; 2018 Apr; ():. PubMed ID: 29644623
[TBL] [Abstract][Full Text] [Related]
10. Low- and High-Pressure Membrane Separation in the Production of Process Water for Coke Quenching.
Trusek A; Wajsprych M; Noworyta A
Membranes (Basel); 2021 Nov; 11(12):. PubMed ID: 34940439
[TBL] [Abstract][Full Text] [Related]
11. Efficiency of ultrafiltration/diafiltration in removing organic and elemental process equipment related leachables from biological therapeutics.
Sun B; Hadidi M; Santiago Nuñez J; Song B; Tumambac GE; Wong K; Kalinowski G; Hathcock JJ
Biotechnol Prog; 2024; 40(1):e3400. PubMed ID: 37964726
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic model of pH and excipient concentration during ultrafiltration and diafiltration processes of therapeutic antibodies.
Ladwig JE; Zhu X; Rolandi P; Hart R; Robinson J; Rydholm A
Biotechnol Prog; 2020 Sep; 36(5):e2993. PubMed ID: 32185869
[TBL] [Abstract][Full Text] [Related]
13. Strategies for high-concentration drug substance manufacturing to facilitate subcutaneous administration: A review.
Holstein M; Hung J; Feroz H; Ranjan S; Du C; Ghose S; Li ZJ
Biotechnol Bioeng; 2020 Nov; 117(11):3591-3606. PubMed ID: 32687221
[TBL] [Abstract][Full Text] [Related]
14. Intermolecular interactions in highly concentrated formulations of recombinant therapeutic proteins.
Baek Y; Zydney AL
Curr Opin Biotechnol; 2018 Oct; 53():59-64. PubMed ID: 29278833
[TBL] [Abstract][Full Text] [Related]
15. Effects of Impurities from Sugar Excipient on Filtrate Flux during Ultrafiltration and Diafiltration Process.
Lee J; Na J; Baek Y
Membranes (Basel); 2021 Oct; 11(10):. PubMed ID: 34677543
[TBL] [Abstract][Full Text] [Related]
16. Theoretical analysis of excipient concentrations during the final ultrafiltration/diafiltration step of therapeutic antibody.
Miao F; Velayudhan A; DiBella E; Shervin J; Felo M; Teeters M; Alred P
Biotechnol Prog; 2009; 25(4):964-72. PubMed ID: 19569193
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
